{"id":"tp-54954","type":"article-newspaper","title":"Protagenic Therapeutics Announces Placement With Up to $5 Million in Potential Proceeds","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/54954","datePublished":"2026-11-12T05:12:19.000Z","dateModified":"2026-11-12T05:12:19.000Z","language":"en","abstract":"The company plans to use proceeds for PT00114 development, working capital and general corporate purposes.","section":"Business","references":[]}